CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,230,845
- in 7 filings, $1.6M under 10b5-1 plans
Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −140 | $45.81 | $6K | 29,860 |
| 2026-04-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,419 | $47.39 | $115K | 27,441 |
| 2026-04-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,441 | $48.06 | $117K | 25,000 |
| 2026-04-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 131,268 | ||
| 2026-03-25 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +40,000 | $2.48 | $99K | 65,000 |
| 2026-03-25 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −40,000 | $35.10 | $1.4M | 25,000 |
| 2026-03-25 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −40,000 | 136,268 | ||
| 2026-03-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +5,000 | $2.48 | $12K | 30,000 |
| 2026-03-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −5,000 | $27.76 | $139K | 25,000 |
| 2026-03-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 176,268 | ||
| 2026-03-10 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,129 | $2.48 | $25K | 35,129 |
| 2026-03-10 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −10,129 | $30.19 | $306K | 25,000 |
| 2026-03-10 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −10,129 | 181,268 | ||
| 2026-03-09 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +29,871 | $2.48 | $74K | 54,871 |
| 2026-03-09 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −29,871 | $30.02 | $897K | 25,000 |
| 2026-03-09 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −29,871 | 191,397 | ||
| 2026-03-06 | Hohl Benjamin CHIEF FINANCIAL OFFICER | Sale | −10,000 | $29.58 | $296K | 51,000 |
| 2026-02-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +45,000 | $2.48 | $112K | 70,000 |
| 2026-02-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Sale 10b5-1 | −45,000 | $26.17 | $1.2M | 25,000 |
| 2026-02-17 | Collins Helen Louise CHIEF MEDICAL OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −45,000 | 221,268 |
Page 5 of 37 · 724 trades